As a fellow in the BIH Charité Clinician Scientist Program at the Department of Neurology with Experimental Neurology at Charité - Universitätsmedizin Berlin, Dr. Simon Hellwig is conducting research on the early detection of serious cardiovascular events after a stroke. He has now received the…
Chemotherapy is often associated with severe neurological side effects. The multicenter study PREPARE led by Charité – Universitätsmedizin Berlin now aims to find out whether preventive lithium administration during chemotherapy can alleviate or even entirely prevent neurological complications in…
Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Germany and the UK, have found that a commonly used liver drug also affects infection with the SARS-CoV-2 coronavirus. It causes the number of ACE-2 receptors on the cells to decrease, which makes it…
The €500,000 Einstein Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The recipient of this year’s international Individual Award is Canadian physician Gordon Guyatt for the…
The monitoring and interdisciplinary research group Gene Technology Report seeks to promote an objective discourse on genetic technologies in Germany. Renowned natural scientists, social scientists, and humanities scholars present the current state of the art in the field through periodic reports…
Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited.…
Leukemia, a blood cancer, occurs when immature immune cells stop developing but keep dividing and eventually inundate the blood. There, they encounter mature and active immune cells that either recognize and kill the cancer cells or let them escape. Dr. Simon Haas, head of a BIH junior research…
Every person has an individual chemical fingerprint. The composition of small molecules in the blood, such as fats or sugars, determines how our body reacts to external influences, which diseases we are susceptible to and how severe an illness will be. In an international collaboration with partners…
Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of impaired glucose tolerance, and help identify individuals at high risk of developing type 2 diabetes. The research, led by scientists from the Berlin Institute of Health at…
Professor Christof von Kalle, BIH Chair for Clinical Translational Sciences and Founding Director of the Clinical Study Center of the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has been awarded the European Society of Gene and Cell Therapy (ESGCT)…
On October 6, an exhibition about arguments is opening at the Museum of Communication. The Brain Simulation Group at the Berlin Institute of Health at Charité (BIH) will be participating with an interactive touchscreen display that visualizes emotions involved in arguments. Visitors will be able to…
To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time. Scientists from the Berlin Institute of Health at…
An international research consortium led by the Berlin Institute of Health at Charité (BIH) has secured funding of €7.5 million through the EU’s current Horizon Europe program. The goal of the participating scientific and clinical specialists is to prevent the pain and cartilage degeneration…
Heart attack patients taking a combination “polypill” made up of the blood thinner ASA as well as substances that lower blood pressure and blood lipid concentrations were less likely to suffer another major cardiovascular event than patients taking three separate pills. That is the finding of the…
MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previously incurable muscle diseases using its innovative muscle stem cell technology. The BIH accelerated…
To be able to act against pathogens, the immune system needs a huge number of matching antibodies. In a study conducted at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), the group led by BIH Professor Kathrin de la Rosa found that a "thieving" mechanism…
“Courage and exceptional dedication” are the qualities that Dr. Peter Bobbert, president of the Berlin Medical Association, sees in those who were recently awarded the Georg Klemperer Prize. Prof. Duška Dragun was honored for her significant contribution to training a new generation of young…
With the GSCN Awards 2022, the German Stem Cell Network recognizes outstanding stem cell researchers on their way to expand basic research and open up new avenues for therapeutic options. The "GSCN 2022 Young Investigator Award" goes to Simon Haas from the Berlin Institute of Health (BIH), the…
A large number of people are currently contracting COVID-19. Fortunately, most of them are experiencing only mild symptoms, largely thanks to the high vaccination rate. However, in some individuals the disease takes a much more severe cause and our understanding about the underlying reasons is still…
The European Research Council (ERC) has awarded Professor Georg Duda of the Berlin Institute of Health at Charité (BIH) an ERC Advanced Grant worth €2.5 million. His sponsored project explores the budding field of immunomechanics, which studies how the immune system and tissue mechanics interact…
A Berlin-based research group led by Charité - Universitätsmedizin Berlin has succeeded in simulating SARS-CoV-2 infection in human lungs and has gained important insights into the mechanism of infection. Using living lung samples, they were able to show that the virus is capable of directly…
The Innovation Committee at the Federal Joint Committee (G-BA) is funding FAIR4Rare as one of 32 new projects in the field of health care research. In particular, it supports the evaluation of the pilot phase of an open National Registry for Rare Diseases (NARSE).
Blood vessels must adapt their growth to the nutrients available in their surroundings so that they can keep organs adequately supplied. A team led by Michael Potente has identified two proteins that are important for this process and published their findings in Nature Metabolism.
Prof. Maike Sander has been named the new Scientific Director of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), which is the Privileged Partner of the Berlin Institute of Health at Charité (BIH). The BIH Board of Directors warmly welcomes the diabetes researcher…
During an epileptic seizure, groups of neurons suddenly fire all at once, leading to involuntary movements and sensations. Possibilities for helping those who suffer from epilepsy are limited. EpiBlok Therapeutics GmbH was recently founded by scientists from Charité and the Medical University of…
On Thursday, June 9, 2022, Judith Pirscher, State Secretary at the German Federal Ministry of Education and Research (BMBF), visited the Berlin Institute of Health at Charité (BIH). As the State Secretary responsible for life sciences and Chair of the BIH Governing Board, she gained an overview of…
On Wednesday, June 8, 2022, members of the German Bundestag Michael Müller and Ruppert Stüwe, both of the Social Democratic Party (SPD), visited the Berlin Institute of Health at the Charité (BIH). As former mayor and science senator of Berlin, Müller actively oversaw the BIH’s integration into…
The EBRAIN-Health project, led by Prof. Dr. Petra Ritter, BIH Johanna Quandt Professor of Brain Simulation and Head of the Brain Simulation research group at the Berlin Institute of Health at Charité (BIH) and Head of Charité’s Department of Neurology and Experimental Neurology, aims to develop a…
Effective July 1, 2022, Ludovic Vallier will take up the W3 Einstein Strategic Professorship for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité (BIH). Vallier is an expert in pluripotent stem cells and organoids. He uses these versatile cells to grow liver cells,…
On May 31, 2022, the Digital Health Accelerator Program of the Berlin Institute of Health at Charité (BIH) will celebrate its fifth anniversary. This special occasion will include talks by successful grantees and committed supporters, as well as pitches by the seven 2022 funded teams of young…
